Bristol-Myers Squibb Co.: The newly merged drug...
- Share via
Bristol-Myers Squibb Co.: The newly merged drug manufacturer said its two predecessor companies had a combined 16% increase in third-quarter profit to $410.7 million. Combined revenue totaled $2.3 billion, up 6%. The company cited stronger domestic sales and improved international revenue. New York-based Bristol-Myers makes Excedrin and Bufferin pain relievers, household products and prescription medicines. Squibb, based in Princeton, N.J., makes prescription drugs.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
